In multiple myeloma increased thrombopoietin (Tpo) production may be involved in the maintenance of platelet production.
In multiple myeloma (MM), suppression of haematopoiesis occurs as a result of expansion of malignant cells in the bone marrow. Thrombopoietin (Tpo) levels in patients with impaired platelet production are generally found to be highly elevated. To examine the circulating Tpo levels in patients with MM, Tpo levels were measured in 50 serum samples from 34 patients. Tpo levels were subsequently related to disease stage, and cell numbers and markers, i.e. platelet count, leukocyte count and haemoglobin (Hb) concentration. Elevated Tpo levels were found in association with decreased platelet counts (n=8), but also in patients with normal platelet counts (n=14). The latter group included patients without and with signs of impaired haematopoiesis, i.e. with decreased Hb concentration and decreased leukocyte count. These results show that neither platelet counts nor Tpo levels are reliable parameters to judge bone-marrow failure in patients with MM. Furthermore, in patients with MM, increased Tpo levels may play a role in the maintenance of thrombocytopoiesis. The origin of the increased Tpo levels remains to be determined.
Folman
C C
CC
Division of Internal Medicine and Department of Haematology, Academic Medical Centre, Amsterdam, The Netherlands.
de Jong
C M
CM
de Haas
M
M
von dem Borne
A E
AE
D000368:Aged; D000369:Aged, 80 and over; D001792:Blood Platelets; D005260:Female; D006410:Hematopoiesis / Q000502:physiology*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood*; D010976:Platelet Count; D012189:Retrospective Studies; D013926:Thrombopoietin / Q000097:blood*
D006454:Hemoglobins; D013926:Thrombopoietin